Blanke O, Faivre N, and Dieguez S. Leaving Body and Life Behind: Out-of-Body and Near-Death Experience. In: The Neurology of Consciousness. London: Academic Press, 2016, 323–47.
Brouwer A, Carhart-Harris RL. Pivotal mental states. J Psychopharmacol 2021;35:319–52.
Carhart-Harris R, Roseman L, Haijen E et al. Psychedelics and the essential importance of context. J Psychopharmacol 2018;32:725–31.
Charland-Verville V, Jourdan J-P, Thonnard M et al. Near-death experiences in non-life-threatening events and coma of different etiologies. Front Hum Neurosci 2014;8:203.
Corazza O, Schifano F. Near-death states reported in a sample of 50 misusers. Subst Use Misuse 2010;45:916–24.
D’Argembeau A, Van der Linden M. Remembering pride and shame: self-enhancement and the phenomenology of autobiographical memory. Memory 2008;16:538–47.
Davis AK, Barrett FS, Griffiths RR. Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. J Contextual Behav Sci 2020;15:39–45.
Davis AK, Barrett FS, So S et al. Development of the psychological insight questionnaire among a sample of people who have consumed psilocybin or LSD. J Psychopharmacol 2021;35:437–46.
Dean JG, Liu T, Huff S et al. Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain. Sci Rep 2019;9:9333.
Farnes N, Juel BE, Nilsen AS et al. Increased signal diversity/complexity of spontaneous EEG, but not evoked EEG responses, in ketamine-induced psychedelic state in humans. PLoS One 2020;15:e0242056.
Fritz P, Lejeune N, Cardone P et al. Bridging the gap: (A)typical psychedelic and near-death experience insights. Curr Opin Beh Sci 2024;55:101349.
Greyson B, Stevenson I. The phenomenology of near-death experiences. Am J Psychiatry 1980;137:1193–6.
Griffiths RR, Richards WA, McCann U et al. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 2006;187:268–83.
Groth-Marnat G, Summers R. Altered beliefs, attitudes, and behaviours following near death experiences. J Hum Psychol 1998;38:110–25.
James W. The Varieties of Religious Experience. Cambridge, MA: Harvard University Press, 1902.
Johnson MK, Foley MA, Suengas AG et al. Phenomenal characteristics of memories for perceived and imagined autobiographical events. J Exp Psychol Gen 1988;117:371–6.
Kellehear A. Culture, biology, and the near-death experience: A reappraisal. J Nerv Ment 1993;181:148–56.
Knoblauch PH, Schmied I, Schnettler B. Different kinds of near-death experience: A report on a survey of near-death experiences in Germany. J Near Death Stud 2001;20:15–29.
Martial C, Cassol H, Antonopoulos G et al. Temporality of features in near-death experience narratives. Front Hum Neurosci 2017;11:311.
Martial C, Cassol H, Charland-Verville V et al. Neurochemical models of near-death experiences: a large-scale study based on the semantic similarity of written reports. Conscious Cogn 2019;69:52–69.
Martial C, Cassol H, Laureys S et al. Near-death experience as a probe to explore (disconnected) consciousness. Trends Cognit Sci 2020b;24:173–83.
Martial C, Fontaine G, Gosseries O et al. Losing the self in near-death experiences: the experience of ego-dissolution. Brain Sci 2021;11:929.
Martial C, Simon J, Puttaert N et al. The Near-Death Experience Content (NDE-C): Development and psychometric validation. Conscious Cogn 2020a;86:103049.
Michael P, Luke D, Robinson O. This is your brain on death: a comparative analysis of a near-death experience and subsequent 5-Methoxy-DMT experience. Front Psychol 2023;14:1083361.
Moody RA. Life after Life. New York: Bantam Books, 1975.
Nour MM, Evans L, Nutt D et al. Ego-dissolution and psychedelics: Validation of the Ego-Dissolution Inventory (EDI). Front Hum Neurosci 2016;10:269.
Noyes R, Fenwick P, Holden JM et al. Aftereffects of pleasurable Western adult near-death experiences. In: Holden JM, Greyson B, James D (eds.), The Handbook of Near-death Experiences: Thirty Years of Investigation. Santa Barbara, CA: Praeger/ABC-CLIO, 2009, 41–62.
Olson JA, Suissa-Rocheleau L, Lifshitz M et al. Tripping on nothing: placebo psychedelics and contextual factors. Psychopharmacology 2020;237:1371–82.
Peill JM, Trinci KE, Kettner H et al. Validation of the psychological insight scale: A new scale to assess psychological insight following a psychedelic experience. J Psychopharmacol 2022;36:31–45.
Perera M, Padmasekara G, Belanti JW. Prevalence of near-death experiences in Australia. J Near Death Stud 2005;24:109–16.
Ring K. Heading toward Omega: In Search of the Meaning of the Near-death Experience. New York: Coward McCann & Geoghenan, 1984.
Roseman L, Leech R, Feilding A et al. The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers. Front Hum Neurosci 2014;8:204.
Roseman L, Nutt DJ, Carhart-Harris RL. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol 2018;8:974.
Rouder JN, Morey RD, Speckman PL et al. Default Bayes factors for ANOVA designs. J Math Psychol 2012;56:356–74.
Schmied I, Knoblaub H, Schnettler B. Todesnaheerfahrungen in Ost- und Westdeutschland: Ein empirische Untersuchung. In: Knoblaub H, Soeffner HG (eds.), Todesnähe: Interdisziplinäre Zugänge Zu Einem Außergewöhnlichen Phänomen. Konstanz: Universiätsverlag Konstanz, 1999, 65–99.
Schwaninger J, Eisenberg P, Schechtman K et al. A prospective analysis of near-death experiences in cardiac arrest patients. J Near Death Stud 2002;20:215–32.
Studerus E, Gamma A, Vollenweider FX. Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS One 2010;5:e12412.
Sweeney MM, Nayak S, Hurwitz ES et al. Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying. PLoS ONE 2022;17:e0271926.
Tassell-Matamua NA, Lindsay N. “I’m not afraid to die”: the loss of the fear of death after a near-death experience. Mortality 2016;21:71–87.
Thonnard M, Charland-Verville V, Brédart S et al. Characteristics of near-death experiences memories as compared to real and imagined events memories. PloS One 2013;8:e57620.
Timmermann C, Kettner H, Letheby C et al. Psychedelics alter metaphysical beliefs. Sci Rep 2021;11:22166.
Timmermann C, Roseman L, Williams L et al. DMT models the near-death experience. Front Psychol 2018;9:1424.
Timmermann C, Watts R, Dupuis D. Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations. Transcult Psychiatry 2022;59:691–704.
Timmermann C, Zeifman RJ, Erritzoe D et al. Effects of DMT on mental health outcomes in healthy volunteers. Sci Rep 2024; 14:3097.
Uthaug MV, Lancelotta R, Szabo A et al. Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment. Psychopharmacology 2020;237:773–85.
van Lommel P, van Wees R, Meyers V et al. Near-death experience in survivors of cardiac arrest: a prospective study in the Netherlands. Lancet 2001;358: 2039–45.
